Mercado de dispositivos de neuroestimulação interna da Ásia-Pacífico, por tipo de produto ( estimulação da medula espinhal (SCS), estimulação cerebral profunda , estimulação do nervo vago, estimulação do nervo sacro e estimulação elétrica gástrica ), canal de distribuição (concurso direto e prestador de serviços externalizado) - Tendências do setor e Previsão para 2029.
Análise e insights do mercado de dispositivos de neuroestimulação interna da Ásia-Pacífico
Prevê-se que o aumento da procura de dispositivos internos de neuroestimulação como terapia complementar, o aumento da prevalência e incidência de doenças neurológicas, o aumento do financiamento para os dispositivos de neuroestimulação, os avanços tecnológicos nos dispositivos internos de neuroestimulação e o aumento das aprovações de produtos impulsionam o crescimento do mercado.
Espera-se que as iniciativas estratégicas dos participantes do mercado e o aumento do financiamento dos participantes do mercado público e privado para dispositivos internos de neuroestimulação criem oportunidades para o crescimento do mercado. No entanto, espera-se que a falta de especialistas qualificados e treinados em dispositivos internos de neuroestimulação restrinja o crescimento do segmento. Espera-se que a disponibilidade de dispositivos de imagem alternativos desafie o crescimento do mercado.
A Data Bridge Market Research analisa que o mercado interno de dispositivos de neuroestimulação da Ásia-Pacífico crescerá a um CAGR de 16,4% e 3.890,15 milhões de dólares durante o período de previsão de 2022 a 2029.
|
Métrica de reporte |
Detalhes |
|
Período de previsão |
2022 a 2029 |
|
Ano base |
2021 |
|
Anos históricos |
2020 (personalizável para 2019 - 2024) |
|
Unidades Quantitativas |
Receita em milhões de dólares, preços em dólares |
|
Segmentos cobertos |
Por tipo de produto (estimulação da medula espinhal (SCS), estimulação cerebral profunda, estimulação do nervo vago, estimulação do nervo sacro e estimulação elétrica gástrica), canal de distribuição (concurso direto e prestador de serviços terceirizado) |
|
Países abrangidos |
China, Japão, Coreia do Sul, Índia, Austrália, Singapura, Tailândia, Malásia, Indonésia, Filipinas e restante Ásia-Pacífico |
|
Participantes do mercado abrangidos |
Medtronic, LivaNova PLC, Abbott, Microsemi (uma subsidiária da Microchip Technology Inc.), Boston Scientific Corporation, Integer Holdings Corporation, GIMER Medical, Bionic Vision Technologies., NEVRO CORP., Valencia Technologies, CIRTEC, Sequana Medical NV, BIOINDUCTION, ONWARD , Axonics, Inc., entre outros |
Definição de mercado
Um dispositivo de neuroestimulação interna é um dispositivo colocado cirurgicamente. Fornece sinais elétricos suaves ao espaço epidural junto à coluna vertebral através de um ou mais fios finos chamados elétrodos. A neuroestimulação proporciona alívio da dor ao interromper os sinais de dor que viajam entre a medula espinal e o cérebro.
Os dispositivos de neuroestimulação incluem abordagens invasivas e não invasivas que envolvem estimulação elétrica para impulsionar a função neural dentro de um circuito. O aumento da procura de dispositivos de neuroestimulação interna deve-se às progressões tecnológicas de próxima geração nos dispositivos de neuroestimulação, proporcionando o tão necessário alívio terapêutico a um número sem precedentes de pessoas afetadas por distúrbios neurológicos e psiquiátricos debilitantes em todo o mundo. A ascensão das terapias modernas de neuromodulação aumentou ao longo de meio século, rica em descobertas fortuitas e avanços tecnológicos que levaram a diferentes estratégias de neuroestimulação. Nas últimas duas décadas, a inovação na tecnologia de dispositivos médicos começou a impulsionar a evolução destes sistemas de neuroestimulação a um ritmo mais acelerado
O conveniente dispositivo de neuroestimulação interna utilizado pelos doentes é a estimulação do nervo vago. O dispositivo de neuroestimulação vago utiliza um dispositivo para estimular o nervo vago com impulsos elétricos. Um estimulador implantável do nervo vago está atualmente aprovado pela FDA para tratar a epilepsia e a depressão. Existe um nervo vago de cada lado do corpo, que vai desde o tronco cerebral, passando pelo pescoço, até ao tórax e abdómen. No futuro, os avanços de software, como a estimulação em circuito fechado e a programação remota, permitirão que os dispositivos internos de neuroestimulação sejam uma tecnologia mais personalizada e acessível. Espera-se que o futuro dos dispositivos de neuroestimulação interna melhore ainda mais a qualidade de vida.
Dinâmica do mercado de dispositivos de neuroestimulação interna da Ásia-Pacífico
Esta secção trata da compreensão dos impulsionadores do mercado, das oportunidades, das restrições e dos desafios. Tudo isto é discutido em detalhe abaixo:
Motoristas
- Aumento da prevalência e incidência de doenças neurológicas
Os dispositivos têm a capacidade de capacitação da instituição e dos produtos e resultados pretendidos. Cerca de uma em cada seis pessoas da população mundial sofre de doenças neurológicas, incluindo a doença de Alzheimer, a doença de Parkinson, a demência, a epilepsia e a enxaqueca. A prevalência de perturbações neurológicas incapacitantes graves aumenta com a idade. Assim, os governos de todo o mundo enfrentam uma procura crescente de serviços de tratamento, reabilitação e apoio para doenças neurológicas.
Por exemplo,
- Em 2019, na Índia, os dados da Neurology India afirmaram que os distúrbios neurológicos comuns são o acidente vascular cerebral (37,9%), seguido pela dor de cabeça (17,5%), epilepsia (11,3%) e paralisia cerebral (5,7%)
Uma vez que as empresas estão constantemente envolvidas em atividades de investigação e desenvolvimento, o conhecimento sobre a prevalência e incidência de doenças neurodegenerativas ajudaria a encontrar novas soluções e ajudaria em mais colaborações e parcerias com intervenientes no mercado nos EUA, na Europa e na região Ásia-Pacífico . Isto significa o aumento dos investimentos relacionados com a investigação e desenvolvimento para a descoberta e desenvolvimento de dispositivos de neuroestimulação interna avançados e indolores, que deverão impulsionar o crescimento do mercado.
- Procura de dispositivos internos de neuroestimulação como terapia complementar
O tratamento da dor neurológica pode incluir dor farmacológica, métodos fisioterapêuticos e invasivos. Um número considerável de doentes não consegue alívio suficiente da dor com a farmacoterapia; nestes doentes com dor neuropática pode ser aplicada neuroestimulação elétrica.
Por exemplo,
- A terapia de estimulação do nervo vago (VNS) da LivaNova PLC. é um tratamento neuromodulador desenvolvido para pessoas com epilepsia resistente à medicação com quatro anos de idade ou mais, com crises parciais. Pode levar com segurança a menos e mais curtas convulsões e melhor recuperação após convulsões
A sensibilização para o tratamento precoce da síndrome neurológica e a utilização de dispositivos internos de neuroestimulação faria com que os intervenientes no mercado colaborassem com as instituições de saúde para fornecer e distribuir os dispositivos. Isto resultará num aumento na expansão de produtos e linhas de negócio. Assim, espera-se que a consciencialização entre as pessoas sobre o tratamento atempado e a utilização de dispositivos internos de neuroestimulação impulsione o crescimento do mercado.
Oportunidades
- Iniciativas Estratégicas dos Participantes no Mercado
A procura por dispositivos internos de neuroestimulação está a aumentar no mercado devido ao aumento dos níveis de investigação e desenvolvimento, juntamente com o crescimento do mercado interno de dispositivos de neuroestimulação auxiliado pelo desejo de medicamentos inovadores. Assim, os principais players do mercado implementaram uma nova estratégia desenvolvendo novos dispositivos e equipamentos, colaborando com outros players do mercado e melhorando as operações comerciais e a rentabilidade.
Por exemplo,
- Em janeiro de 2021, a Boston Scientific começou a enviar as suas estruturas de gatilho de linha espinal Wave Writer Alpha para os EUA
- Em maio de 2019, os Laboratórios Abbott estabeleceram uma parceria com o NIH na iniciativa BRAIN (Brain Research through Advancing Innovative Neurotechnologies) para acelerar os avanços na ciência neurológica
Assim, as empresas que operam globalmente no mercado dos dispositivos de neuroestimulação estão a adotar a colaboração para aumentar o seu portefólio de produtos com produtos ricos em tecnologia avançada para impulsionar os seus negócios em diversas dimensões. Assim, espera-se que as iniciativas estratégicas dos principais players do mercado ofereçam oportunidades significativas para os players do mercado que operam no mercado interno de dispositivos de neuroestimulação da Ásia-Pacífico.
- Desenvolvimentos recentes de produtos em dispositivos internos de neuroestimulação
A curva de crescimento do mercado interno de dispositivos de neuroestimulação da Ásia-Pacífico segue uma tendência ascendente devido à procura de terapias neurovasculares eficazes que aumenta constantemente devido à crescente prevalência de doenças neurovasculares (como epilepsia, acidente vascular cerebral e aneurisma cerebral) e à gravidade de doenças (como corrimento e distúrbios adjacentes) nos doentes-alvo. Devido à crescente prevalência e à crescente consciencialização sobre a gravidade destas doenças, vários equipamentos ou dispositivos são fabricados ou estão em fase de ensaios clínicos.
- Em julho de 2022, a NeuraLace anunciou a autorização da FDA para o seu sistema de estimulação nervosa periférica externa para aliviar a dor neuropática
- Em dezembro de 2020, a Motility Medical anunciou um ensaio clínico de um estimulador abdominal transcutâneo em doentes com obstipação crónica, incluindo por lesão medular
The clinical trials and product development in recent years have shown the potential of these technologies and the companies working in this market are trying to get the more advanced product in the market which will act as an opportunity for the market and propel the market in the forecast período.
Restrições/Desafios
- Riscos associados à implementação destes dispositivos
Os implantes médicos apresentam vários perigos, incluindo os relacionados com a cirurgia durante a instalação ou remoção, infeção e falha do implante. Os materiais utilizados nos implantes podem potencialmente causar respostas em algumas pessoas. Todo o procedimento cirúrgico traz algum risco. Isto inclui hematomas, desconforto, inchaço e vermelhidão no local da cirurgia. Assim, dificultará proporcionalmente o crescimento dos dispositivos de implante. A crescente consciencialização sobre os riscos crescentes relacionados com os implantes de neuroestimulação pode, portanto, dificultar o crescimento do mercado.
Por exemplo,
- Falha do implante
- Riscos cirúrgicos durante a colocação ou remoção.
- Risco de sequestro de dispositivos implantáveis.
- Aumento de infeções
- Os materiais utilizados em implantes podem apresentar reações adversas em pacientes
Os riscos acima mencionados podem dificultar o crescimento do mercado interno de dispositivos de neuroestimulação, uma vez que os riscos relacionados com os doentes são de grande importância. Assim, a consciência dos potenciais riscos dos dispositivos implantáveis funciona como um desafio para o mercado interno de dispositivos de neuroestimulação da Ásia-Pacífico.
Falta de profissionais de saúde qualificados
Os dispositivos de neuroestimulação são dispositivos médicos implantáveis e programáveis que fornecem estimulação elétrica a partes específicas do cérebro, medula espinhal ou sistema nervoso periférico do paciente para ajudar a tratar várias condições, incluindo dor crónica, distúrbios do movimento, epilepsia e doença de Parkinson. Estas tecnologias poderosas requerem um procedimento de desenvolvimento de elevado custo e profissionais qualificados para manusear dispositivos sensíveis. O custo estimado dos dispositivos de neuroestimulação é de aproximadamente 22.970 dólares, ou seja, 1.827.200,33 rupias indianas. A substituição deve ser feita a cada 3-6 anos após a implantação, o que é um custo dispendioso e normalmente sai do bolso para a maioria dos doentes.
Apenas um número relativamente pequeno de doentes nos países mais pobres pode pagar a terapia neurológica devido aos preços elevados, a um ambiente de reembolso fraco e à falta de recursos de cuidados de saúde qualificados. Como resultado, as unidades de saúde hesitam em gastar dinheiro em tecnologias novas ou de ponta, limitando a expansão do mercado interno de neuroestimulação. Assim, estes desafios podem dificultar o crescimento do mercado.
Impacto do COVID-19 no mercado interno de dispositivos de neuroestimulação da Ásia-Pacífico
Durante a pandemia, o mercado interno de dispositivos de neuroestimulação da Ásia-Pacífico concentrou-se na utilização de uma combinação de biologia e tecnologia da informação. Durante a pandemia de COVID-19, novos desafios terapêuticos foram acrescentados aos habituais nos dispositivos internos de neuroestimulação. Os doentes com dispositivo implantável para infusão intratecal necessitam de reabastecimento da bomba para evitar a síndrome de abstinência. Os doentes com implantes de neuroestimulação podem necessitar de exames em caso de infeção, deiscência da ferida ou migração do elétrodo.
Desenvolvimentos recentes
- Em janeiro de 2022, a Medtronic recebeu a aprovação do produto da Food and Drug Administration (FDA) para o neuroestimulador recarregável Intellis, uma terapia de estimulação da medula espinhal para o tratamento da dor crónica resultante da neuropatia periférica diabética. A aprovação do produto recebida resultou na adição de um novo produto na categoria de produtos para estimulação da medula espinhal. A aprovação é esperada para aprovação pós-comercialização no mercado dos EUA
- Em julho de 2022, a Abbott recebeu a aprovação da Food and Drug Administration (FDA) para o sistema de estimulação cerebral profunda Infinity para tratar a depressão. A aprovação recebida resultou no aumento do início da aprovação pré e pós-comercialização e na adição de um novo produto ao portfólio de produtos
Âmbito do mercado de dispositivos de neuroestimulação interna da Ásia-Pacífico
O mercado interno de dispositivos de neuroestimulação da Ásia-Pacífico está categorizado por tipo de produto e canal de distribuição. O crescimento entre estes segmentos irá ajudá-lo a analisar os escassos segmentos de crescimento nas indústrias e fornecer aos utilizadores uma valiosa visão geral do mercado e insights de mercado para os ajudar a tomar decisões estratégicas para identificar as principais aplicações do mercado.
Tipo de produto
- Estimulação da Medula Espinhal (SCS)
- Estimulação cerebral profunda
- Estimulação do nervo vago
- Estimulação do Nervo Sacral
- Estimulação Elétrica Gástrica
Com base no tipo de produto, o mercado interno de dispositivos de neuroestimulação da Ásia-Pacífico está segmentado em estimulação da medula espinhal (SCS), estimulação cerebral profunda, estimulação do nervo vago , estimulação do nervo sacral, estimulação elétrica gástrica.
Canal de Distribuição
- Concurso Direto
- Prestador de serviços terceirizado
Com base no canal de distribuição, o mercado interno de dispositivos de neuroestimulação da Ásia-Pacífico está segmentado em oferta direta e prestador de serviços terceirizados.
Análise/perspetivas regionais do mercado de dispositivos de neuroestimulação interna da Ásia-Pacífico
O mercado interno de dispositivos de neuroestimulação da Ásia-Pacífico é analisado, o tipo de produto e o canal de distribuição, como mencionado acima.
Alguns países abrangidos pelo mercado interno de dispositivos de neuroestimulação da Ásia-Pacífico são a China, o Japão, a Coreia do Sul, a Índia, a Austrália, Singapura, a Tailândia, a Malásia, a Indonésia, as Filipinas e o resto da Ásia-Pacífico. Espera-se que a China domine o mercado devido ao aumento da atividade de investigação e desenvolvimento e aos requisitos internos integrados de dispositivos de neuroestimulação em diagnósticos proteómicos, genómicos e clínicos, combinados com a crescente procura de dispositivos avançados de neuroestimulação no tratamento da dor crónica .
A secção do país do relatório também fornece fatores individuais que impactam o mercado e alterações nas regulamentações do mercado interno que impactam as tendências atuais e futuras do mercado. Pontos de dados como novas vendas, vendas de reposição, demografia do país, epidemiologia de doenças e tarifas de importação e exportação são alguns dos principais indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, são considerados a presença e a disponibilidade de marcas da Ásia-Pacífico e os desafios enfrentados devido à grande ou escassa concorrência de marcas locais e nacionais que impactam os canais de vendas, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.
Análise do panorama competitivo e da quota de mercado dos dispositivos de neuroestimulação interna da Ásia-Pacífico
O panorama competitivo do mercado interno de dispositivos de neuroestimulação da Ásia-Pacífico fornece detalhes sobre o concorrente. Os detalhes incluem a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença na Ásia-Pacífico, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa, lançamento de produtos, largura e amplitude do produto e domínio de aplicação. Os dados acima fornecidos estão apenas relacionados com o foco das empresas relacionado com o mercado interno de dispositivos de neuroestimulação da Ásia-Pacífico.
Alguns dos principais players que operam no mercado interno de dispositivos de neuroestimulação da Ásia-Pacífico são a Medtronic, LivaNova PLC, Abbott, Microsemi (uma subsidiária da Microchip Technology Inc.), Boston Scientific Corporation, Integer Holdings Corporation, GIMER Medical, Bionic Vision Technologies ., NEVRO CORP., Valencia Technologies, CIRTEC, Sequana Medical NV, BIOINDUCTION, ONWARD, Axonics, Inc., entre outros.
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Índice
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET POSITION GRID
2.8 THE CATEGORY VS TIME GRID
2.9 SECONDARY SOURCES
2.1 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL
4.2 PORTER'S FIVE FORCES MODEL
4.3 PIPELINE ANALYSIS FOR INTERNAL NEUROSTIMULATION DEVICES MARKET
5 REGULATIONS OF ASIA PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET
6 EPIDEMIOLOGY OF DISEASES
6.1 INCIDENCE OF ISCHEMIA
6.2 INCIDENCE OF PARKINSON'S DISEASE
6.3 INCIDENCE OF FAILED BACK SYNDROME
6.4 INCIDENCE OF TREMOR
6.5 INCIDENCE OF DEPRESSION
6.6 INCIDENCE OF URINE INCONTINENCE
6.7 INCIDENCE OF FECAL INCONTINENCE
6.8 INCIDENCE RATE OF EPILEPSY
6.9 INCIDENCE OF GASTROPARESIS
6.1 PREVALENCE OF OBESITY
7 EPIDEMIOLOGY OF NEUROSTIMULATION PROCEDURES
7.1 NUMBER OF SPINAL CORD STIMULATION (SCS) PROCEDURES
7.1.1 NUMBER OF TEST PROCEDURES
7.1.2 NUMBER OF IMPLANTATION PROCEDURES
7.2 NUMBER OF DEEP BRAIN STIMULATION PROCEDURES
7.3 NUMBER OF VAGUS NERVE STIMULATION PROCEDURES
7.4 NUMBER OF SACRAL NEVER STIMULATION PROCEDURES
7.5 NUMBER OF TRANSCRANIAL MAGNETIC STIMULATION (TMS) PROCEDURES
7.6 NUMBER OF INTERMITTENT THETA BURST STIMULATION (ITBS) PROCEDURES
7.7 NUMBER OF TRANSCRANIAL DIRECT ELECTRICAL STIMULATION (TDCS) PROCEDURES
8 MARKET OVERVIEW
8.1 DRIVERS
8.1.1 RISE IN PREVALENCE AND INCIDENCE OF NEUROLOGICAL DISORDERS
8.1.2 DEMAND FOR INTERNAL NEUROSTIMULATION DEVICES AS A ADD ON THERAPY
8.1.3 INCREASED FUNDING FOR THE NEUROSTIMULATION DEVICES
8.1.4 TECHNOLOGICAL ADVANCEMENTS IN THE INTERNAL NEUROSTIMULATION DEVICES
8.1.5 RISE IN PRODUCT APPROVALS
8.2 RESTRAINTS
8.2.1 RISE IN COST OF THE DEEP BRAIN STIMULATION DEVICES
8.2.2 RISKS NOTICED WHILE USING THE INTERNAL NEUROSTIMULATION DEVICES
8.2.3 RISE IN PRODUCT RECALL
8.2.4 AVAILABILITY OF ALTERNATE IMAGING DIAGNOSTIC DEVICES
8.3 OPPORTUNITIES
8.3.1 STRATEGIC INITIATIVES BY THE KEY MARKET PLAYER
8.3.2 RECENT PRODUCT DEVELOPMENTS IN THE INTERNAL NEUROSTIMULATION DEVICES
8.3.3 DEMAND FOR MINIMALLY INVASIVE SURGERY
8.4 CHALLENGES
8.4.1 RISKS ASSOCIATED WITH THE IMPLANTATION OF THESE DEVICES
8.4.2 LACK OF SKILLED HEALTHCARE PROFESSIONALS
9 ASIA PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE
9.1 OVERVIEW
9.2 SPINAL CORD STIMULATION
9.2.1 SPINAL CORD STIMULATION, BY TYPE
9.2.1.1 BATTERY
9.2.1.1.1 RECHARGEABLE
9.2.1.1.2 NON-RECHARGEABLE
9.2.1.2 LEAD
9.2.1.2.1 PERCUTANEOUS
9.2.1.2.2 PADDLE
9.2.2 SPINAL CORD STIMULATION, BY APPLICATION
9.2.2.1 ISCHEMIA
9.2.2.2 CHRONIC LOW BACK PAIN (CLBP)
9.2.2.3 DIABETIC NEUROPATHY
9.2.2.4 FAILED BACK SYNDROME
9.3 DEEP BRAIN STIMULATION
9.3.1 DEEP BRAIN STIMULATION, BY TYPE
9.3.1.1 SINGLE CHANNEL DEEP BRAIN STIMULATOR
9.3.1.2 DOUBLE CHANNEL DEEP BRAIN STIMULATOR
9.3.1.3 BATTERY
9.3.1.3.1 RECHARGEABLE
9.3.1.3.2 NON-RECHARGEABLE
9.3.1.4 LEAD
9.3.2 DEEP BRAIN STIMULATION, BY APPLICATION
9.3.2.1 PARKINSON’S DISEASE
9.3.2.2 TREMOR
9.3.2.3 DEPRESSION
9.4 SACRAL NERVE STIMULATION
9.4.1 SACRAL NERVE STIMULATION, BY TYPE
9.4.1.1 BATTERY
9.4.1.2 LEAD
9.5 SACRAL NERVE STIMULATION, BY APPLICATION
9.5.1 URINE INCONTINENCE
9.5.2 FECAL INCONTINENCE
9.6 VAGUS NERVE STIMULATION
9.6.1 VAGUS NERVE STIMULATION, BY TYPE
9.6.1.1 BATTERY
9.6.1.2 LEAD
9.6.2 VAGUS NERVE STIMULATION, BY APPLICATION
9.6.2.1 EPILEPSY
9.6.2.2 OTHERS
9.7 GASTRIC ELECTRICAL STIMULATION
9.7.1 GASTRIC ELECTRICAL STIMULATION, BY TYPE
9.7.1.1 BATTERY
9.7.1.2 LEAD
9.7.2 GASTRIC ELECTRICAL STIMULATION, BY APPLICATION
9.7.2.1 GASTROPARESIS
9.7.2.2 OTHERS
10 ASIA PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 DIRECT TENDER
10.3 THIRD PARTY PROVIDER
11 ASIA PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET, BY REGION
11.1 ASIA-PACIFIC
11.1.1 CHINA
11.1.2 JAPAN
11.1.3 SOUTH KOREA
11.1.4 INDIA
11.1.5 AUSTRALIA
11.1.6 SINGAPORE
11.1.7 THAILAND
11.1.8 MALAYSIA
11.1.9 INDONESIA
11.1.10 PHILIPPINES
11.1.11 REST OF ASIA-PACIFIC
12 ASIA PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
13 SWOT ANALYSIS
14 COMPANY PROFILE
14.1 MEDTRONIC (2021)
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENTS
14.2 BOSTON SCIENTIFIC CORPORATION (2021)
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENTS
14.3 ABBOTT (2021)
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 LIVANOVA PLC (2021)
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 COMPANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENTS
14.5 NEVRO CORP. (2021)
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 COMPANY SHARE ANALYSIS
14.5.4 PRODUCT PORTFOLIO
14.5.5 RECENT DEVELOPMENTS
14.6 AXONICS, INC.
14.6.1 COMPANY SNAPSHOT
14.6.2 REVENUE ANALYSIS
14.6.3 PRODUCT PORTFOLIO
14.6.4 RECENT DEVELOPMENTS
14.7 ALEVA NEUROTHERAPEUTICS
14.7.1 COMPANY SNAPSHOT
14.7.2 PRODUCT PORTFOLIO
14.7.3 RECENT DEVELOPMENTS
14.8 BIONIC VISION TECHNOLOGIES.
14.8.1 COMPANY SNAPSHOT
14.8.2 PRODUCT PORTFOLIO
14.8.3 RECENT DEVELOPMENTS
14.9 BLUEWIND MEDICAL
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENTS
14.1 BIOINDUCTION
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENT
14.11 CIRTEC
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENTS
14.12 FINETECH MEDICAL
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT DEVELOPMENTS
14.13 GIMER MEDICAL
14.13.1 COMPANY SNAPSHOT
14.13.2 PRODUCT PORTFOLIO
14.13.3 RECENT DEVELOPMENTS
14.14 INSPIRE MEDICAL SYSTEMS, INC.
14.14.1 COMPANY SNAPSHOT
14.14.2 REVENUE ANALYSIS
14.14.3 PRODUCT PORTFOLIO
14.14.4 RECENT DEVELOPMENTS
14.15 INTEGER HOLDINGS CORPORATION
14.15.1 COMPANY SNAPSHOT
14.15.2 REVENUE ANALYSIS
14.15.3 PRODUCT PORTFOLIO
14.15.4 RECENT DEVELOPMENT
14.16 INBRAIN NEUROELECTRONICS
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENT
14.17 MAINSTAY MEDICAL
14.17.1 COMPANY SNAPSHOT
14.17.2 REVENUE ANALYSIS
14.17.3 PRODUCT PORTFOLIO
14.17.4 RECENT DEVELOPMENTS
14.18 MICROSEMI (A WHOLLY OWNDED SUBSIDIARY OF MICROCHIP TECHNOLOGY INC.)
14.18.1 COMPANY SNAPSHOT
14.18.2 REVENUE ANALYSIS
14.18.3 PRODUCT PORTFOLIO
14.18.4 RECENT DEVELOPMENTS
14.19 MICROTRANSPONDER INC
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENT
14.2 MICRO-LEADS
14.20.1 COMPANY SNAPSHOT
14.20.2 PRODUCT PORTFOLIO
14.20.3 RECENT DEVELOPMENT
14.21 NALU MEDICAL, INC
14.21.1 COMPANY SNAPSHOT
14.21.2 PRODUCT PORTFOLIO
14.21.3 RECENT DEVELOPMENT
14.22 NEURONANO AB
14.22.1 COMPANY SNAPSHOT
14.22.2 PRODUCT PORTFOLIO
14.22.3 RECENT DEVELOPMENTS
14.23 NEURIMPULSE S.R.L.
14.23.1 COMPANY SNAPSHOT
14.23.2 PRODUCT PORTFOLIO
14.23.3 RECENT DEVELOPMENTS
14.24 NEWRONIKA S.P.A.
14.24.1 COMPANY SNAPSHOT
14.24.2 PRODUCT PORTFOLIO
14.24.3 RECENT DEVELOPMENTS
14.25 OPTOGENTECH GMBH.
14.25.1 COMPANY SNAPSHOT
14.25.2 PRODUCT PORTFOLIO
14.25.3 RECENT DEVELOPMENTS
14.26 ONWARD
14.26.1 COMPANY SNAPSHOT
14.26.2 PRODUCT PORTFOLIO
14.26.3 RECENT DEVELOPMENT
14.27 STIMWAVE LLC (2021)
14.27.1 COMPANY SNAPSHOT
14.27.2 PRODUCT PORTFOLIO
14.27.3 RECENT DEVELOPMENTS
14.28 SEQUANA MEDICAL NV (2021)
14.28.1 COMPANY SNAPSHOT
14.28.2 REVENUE ANALYSIS
14.28.3 PRODUCT PORTFOLIO
14.28.4 RECENT DEVELOPMENTS
14.29 VALENCIA TECHNOLOGIES
14.29.1 COMPANY SNAPSHOT
14.29.2 PRODUCT PORTFOLIO
14.29.3 RECENT DEVELOPMENTS
15 QUESTIONNAIRE
16 RELATED REPORTS
Lista de Tabela
TABLE 1 ASIA PACIFIC PREVALENCE OF OBESITY
TABLE 2 ASIA PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 3 ASIA PACIFIC SPINAL CORD STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 4 ASIA PACIFIC SPINAL CORD STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 5 ASIA PACIFIC BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 6 ASIA PACIFIC BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 7 ASIA PACIFIC BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 8 ASIA PACIFIC LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 9 ASIA PACIFIC LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 10 ASIA PACIFIC LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 11 ASIA PACIFIC SPINAL CORD STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 12 ASIA PACIFIC DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, 2020-2029 (USD MILLION)
TABLE 13 ASIA PACIFIC DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 14 ASIA PACIFIC DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 15 ASIA PACIFIC DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 16 ASIA PACIFIC BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 17 ASIA PACIFIC BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 18 ASIA PACIFIC BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 19 ASIA PACIFIC DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 20 ASIA PACIFIC SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, 2020-2029 (USD MILLION)
TABLE 21 ASIA PACIFIC SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 22 ASIA PACIFIC SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 23 ASIA PACIFIC SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 24 ASIA PACIFIC SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 25 ASIA PACIFIC VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, 2020-2029 (USD MILLION)
TABLE 26 ASIA PACIFIC VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 27 ASIA PACIFIC VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 28 ASIA PACIFIC VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 29 ASIA PACIFIC VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 30 ASIA PACIFIC GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, 2020-2029 (USD MILLION)
TABLE 31 ASIA PACIFIC GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 32 ASIA PACIFIC GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 33 ASIA PACIFIC GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 34 ASIA PACIFIC GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 35 ASIA PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 36 ASIA PACIFIC DIRECT TENDER IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 37 ASIA PACIFIC THIRD PARTY PROVIDER IN INTERNAL NEUROSTIMULATION DEVICES MARKET, 2020-2029 (USD MILLION)
TABLE 38 ASIA-PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 39 ASIA-PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 40 ASIA-PACIFIC SPINAL CORD STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 41 ASIA-PACIFIC BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 42 ASIA-PACIFIC BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 43 ASIA-PACIFIC BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 44 ASIA-PACIFIC LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 45 ASIA-PACIFIC LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 46 ASIA-PACIFIC LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 47 ASIA-PACIFIC SPINAL CORD STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 48 ASIA-PACIFIC DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 49 ASIA-PACIFIC DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 50 ASIA-PACIFIC DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 51 ASIA-PACIFIC BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 52 ASIA-PACIFIC BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 53 ASIA-PACIFIC BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 54 ASIA-PACIFIC DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 55 ASIA-PACIFIC SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 56 ASIA-PACIFIC SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 57 ASIA-PACIFIC SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 58 ASIA-PACIFIC SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 59 ASIA-PACIFIC VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 60 ASIA-PACIFIC VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 61 ASIA-PACIFIC VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 62 ASIA-PACIFIC VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 63 ASIA-PACIFIC GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 64 ASIA-PACIFIC GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 65 ASIA-PACIFIC GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 66 ASIA-PACIFIC GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 67 ASIA-PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 68 CHINA INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 69 CHINA SPINAL CORD STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 70 CHINA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 71 CHINA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 72 CHINA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 73 CHINA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 74 CHINA LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 75 CHINA LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 76 CHINA LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 77 CHINA SPINAL CORD STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 78 CHINA DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 79 CHINA DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 80 CHINA DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 81 CHINA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 82 CHINA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 83 CHINA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 84 CHINA DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 85 CHINA SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 86 CHINA SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 87 CHINA SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 88 CHINA SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 89 CHINA VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 90 CHINA VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 91 CHINA VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 92 CHINA VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 93 CHINA GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 94 CHINA GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 95 CHINA GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 96 CHINA GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 97 CHINA INTERNAL NEUROSTIMULATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 98 JAPAN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 99 JAPAN SPINAL CORD STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 100 JAPAN BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 101 JAPAN BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 102 JAPAN BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 103 JAPAN LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 104 JAPAN LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 105 JAPAN LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 106 JAPAN SPINAL CORD STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 107 JAPAN DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 108 JAPAN DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 109 JAPAN DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 110 JAPAN BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 111 JAPAN BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 112 JAPAN BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 113 JAPAN DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 114 JAPAN SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 115 JAPAN SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 116 JAPAN SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 117 JAPAN SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 118 JAPAN VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 119 JAPAN VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 120 JAPAN VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 121 JAPAN VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 122 JAPAN GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 123 JAPAN GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 124 JAPAN GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 125 JAPAN GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 126 JAPAN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 127 SOUTH KOREA INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 128 SOUTH KOREA SPINAL CORD STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 129 SOUTH KOREA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 130 SOUTH KOREA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 131 SOUTH KOREA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 132 SOUTH KOREA LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 133 SOUTH KOREA LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 134 SOUTH KOREA LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 135 SOUTH KOREA SPINAL CORD STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 136 SOUTH KOREA DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 137 SOUTH KOREA DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 138 SOUTH KOREA DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 139 SOUTH KOREA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 140 SOUTH KOREA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 141 SOUTH KOREA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 142 SOUTH KOREA DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 143 SOUTH KOREA SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 144 SOUTH KOREA SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 145 SOUTH KOREA SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 146 SOUTH KOREA SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 147 SOUTH KOREA VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 148 SOUTH KOREA VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 149 SOUTH KOREA VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 150 SOUTH KOREA VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 151 SOUTH KOREA GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 152 SOUTH KOREA GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 153 SOUTH KOREA GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 154 SOUTH KOREA GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 155 SOUTH KOREA INTERNAL NEUROSTIMULATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 156 INDIA INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 157 INDIA SPINAL CORD STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 158 INDIA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 159 INDIA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 160 INDIA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 161 INDIA LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 162 INDIA LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 163 INDIA LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 164 INDIA SPINAL CORD STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 165 INDIA DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 166 INDIA DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 167 INDIA DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 168 INDIA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 169 INDIA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 170 INDIA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 171 INDIA DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 172 INDIA SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 173 INDIA SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 174 INDIA SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 175 INDIA SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 176 INDIA VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 177 INDIA VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 178 INDIA VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 179 INDIA VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 180 INDIA GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 181 INDIA GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 182 INDIA GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 183 INDIA GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 184 INDIA INTERNAL NEUROSTIMULATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 185 AUSTRALIA INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 186 AUSTRALIA SPINAL CORD STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 187 AUSTRALIA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 188 AUSTRALIA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 189 AUSTRALIA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 190 AUSTRALIA LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 191 AUSTRALIA LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 192 AUSTRALIA LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 193 AUSTRALIA SPINAL CORD STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 194 AUSTRALIA DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 195 AUSTRALIA DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 196 AUSTRALIA DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 197 AUSTRALIA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 198 AUSTRALIA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 199 AUSTRALIA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 200 AUSTRALIA DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 201 AUSTRALIA SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 202 AUSTRALIA SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 203 AUSTRALIA SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 204 AUSTRALIA SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 205 AUSTRALIA VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 206 AUSTRALIA VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 207 AUSTRALIA VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 208 AUSTRALIA VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 209 AUSTRALIA GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 210 AUSTRALIA GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 211 AUSTRALIA GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 212 AUSTRALIA GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 213 AUSTRALIA INTERNAL NEUROSTIMULATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 214 SINGAPORE INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 215 SINGAPORE SPINAL CORD STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 216 SINGAPORE BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 217 SINGAPORE BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 218 SINGAPORE BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 219 SINGAPORE LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 220 SINGAPORE LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 221 SINGAPORE LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 222 SINGAPORE SPINAL CORD STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 223 SINGAPORE DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 224 SINGAPORE DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 225 SINGAPORE DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 226 SINGAPORE BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 227 SINGAPORE BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 228 SINGAPORE BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 229 SINGAPORE DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 230 SINGAPORE SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 231 SINGAPORE SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 232 SINGAPORE SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 233 SINGAPORE SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 234 SINGAPORE VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 235 SINGAPORE VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 236 SINGAPORE VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 237 SINGAPORE VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 238 SINGAPORE GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 239 SINGAPORE GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 240 SINGAPORE GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 241 SINGAPORE GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 242 SINGAPORE INTERNAL NEUROSTIMULATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 243 THAILAND INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 244 THAILAND SPINAL CORD STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 245 THAILAND BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 246 THAILAND BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 247 THAILAND BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 248 THAILAND LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 249 THAILAND LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 250 THAILAND LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 251 THAILAND SPINAL CORD STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 252 THAILAND DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 253 THAILAND DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 254 THAILAND DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 255 THAILAND BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 256 THAILAND BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 257 THAILAND BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 258 THAILAND DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 259 THAILAND SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 260 THAILAND SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 261 THAILAND SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 262 THAILAND SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 263 THAILAND VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 264 THAILAND VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 265 THAILAND VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 266 THAILAND VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 267 THAILAND GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 268 THAILAND GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 269 THAILAND GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 270 THAILAND GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 271 THAILAND INTERNAL NEUROSTIMULATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 272 MALAYSIA INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 273 MALAYSIA SPINAL CORD STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 274 MALAYSIA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 275 MALAYSIA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 276 MALAYSIA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 277 MALAYSIA LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 278 MALAYSIA LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 279 MALAYSIA LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 280 MALAYSIA SPINAL CORD STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 281 MALAYSIA DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 282 MALAYSIA DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 283 MALAYSIA DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 284 MALAYSIA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 285 MALAYSIA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 286 MALAYSIA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 287 MALAYSIA DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 288 MALAYSIA SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 289 MALAYSIA SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 290 MALAYSIA SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 291 MALAYSIA SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 292 MALAYSIA VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 293 MALAYSIA VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 294 MALAYSIA VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 295 MALAYSIA VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 296 MALAYSIA GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 297 MALAYSIA GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 298 MALAYSIA GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 299 MALAYSIA GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 300 MALAYSIA INTERNAL NEUROSTIMULATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 301 INDONESIA INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 302 INDONESIA SPINAL CORD STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 303 INDONESIA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 304 INDONESIA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 305 INDONESIA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 306 INDONESIA LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 307 INDONESIA LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 308 INDONESIA LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 309 INDONESIA SPINAL CORD STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 310 INDONESIA DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 311 INDONESIA DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 312 INDONESIA DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 313 INDONESIA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 314 INDONESIA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 315 INDONESIA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 316 INDONESIA DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 317 INDONESIA SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 318 INDONESIA SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 319 INDONESIA SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 320 INDONESIA SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 321 INDONESIA VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 322 INDONESIA VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 323 INDONESIA VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 324 INDONESIA VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 325 INDONESIA GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 326 INDONESIA GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 327 INDONESIA GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 328 INDONESIA GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 329 INDONESIA INTERNAL NEUROSTIMULATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 330 PHILIPPINES INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 331 PHILIPPINES SPINAL CORD STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 332 PHILIPPINES BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 333 PHILIPPINES BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 334 PHILIPPINES BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 335 PHILIPPINES LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 336 PHILIPPINES LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 337 PHILIPPINES LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 338 PHILIPPINES SPINAL CORD STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 339 PHILIPPINES DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 340 PHILIPPINES DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 341 PHILIPPINES DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 342 PHILIPPINES BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 343 PHILIPPINES BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)
TABLE 344 PHILIPPINES BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 345 PHILIPPINES DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 346 PHILIPPINES SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 347 PHILIPPINES SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 348 PHILIPPINES SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 349 PHILIPPINES SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 350 PHILIPPINES VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 351 PHILIPPINES VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 352 PHILIPPINES VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 353 PHILIPPINES VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 354 PHILIPPINES GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 355 PHILIPPINES GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 356 PHILIPPINES GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)
TABLE 357 PHILIPPINES GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 358 PHILIPPINES INTERNAL NEUROSTIMULATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 359 REST OF ASIA-PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
Lista de Figura
FIGURE 1 ASIA PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET: GEOGRAPHIC SCOPE
FIGURE 3 ASIA PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET: DATA TRIANGULATION
FIGURE 4 ASIA PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET: SNAPSHOT
FIGURE 5 ASIA PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET: BOTTOM UP APPROACH
FIGURE 6 ASIA PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET: TOP DOWN APPROACH
FIGURE 7 ASIA PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET: INTERVIEWS BY REGION AND DESIGNATION
FIGURE 8 ASIA PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET: THE CATEGORY VS TIME GRID
FIGURE 10 ASIA PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET SEGMENTATION
FIGURE 11 INCREASE IN PREVALENCE AND INCIDENCE OF NEUROLOGICAL DISEASES AND DEMAND FOR INTERNAL NEUROSTIMULATION DEVICES AS A ADD ON THERAPY ARE EXPECTED TO DRIVE THE ASIA PACIFIC INTERNAL NEUROSTIMULATIOJ DEVICES MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 SPINAL CORD STIMULATION IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET IN 2022 TO 2029
FIGURE 13 ASIA PACIFIC INCIDENCE OF ISCHEMIA
FIGURE 14 ASIA PACIFIC INCIDENCE OF PARKINSON'S DISEASES
FIGURE 15 ASIA PACIFIC INCIDENCE OF TREMOR
FIGURE 16 ASIA PACIFIC INCIDENCE RATE OF EPILEPSY
FIGURE 17 ASIA PACIFIC INCIDENCE RATE OF GASTROPARESIS
FIGURE 18 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET
FIGURE 19 INCIDENCE OF ADULT ONSET BRAIN DISORDERS IN THE U.S. IN 2021
FIGURE 20 ASIA PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET: BY PRODUCT TYPE, 2021
FIGURE 21 ASIA PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET: BY PRODUCT TYPE, 2022-2029 (USD MILLION)
FIGURE 22 ASIA PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET: BY PRODUCT TYPE, CAGR (2022-2029)
FIGURE 23 ASIA PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 24 ASIA PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 25 ASIA PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 26 ASIA PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 27 ASIA PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 28 ASIA-PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET: SNAPSHOT (2021)
FIGURE 29 ASIA-PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET: BY COUNTRY (2021)
FIGURE 30 ASIA-PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET: BY COUNTRY (2022 & 2029)
FIGURE 31 ASIA-PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET: BY COUNTRY (2021 & 2029)
FIGURE 32 ASIA-PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 33 ASIA PACIFIC INTERNAL NEUROSTIMULATION DEVICES MARKET: COMPANY SHARE 2021 (%)
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.
